Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Halberd Corp (OP: HALB ) 0.0064 UNCHANGED Streaming Delayed Price Updated: 3:43 PM EDT, Aug 5, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Halberd Corp < Previous 1 2 3 4 5 Next > Halberd Achieves Landmark Selective Elimination of Tau From an Antigen Mixture February 01, 2022 Tau has been shown to be important in the development of Alzheimer's Disease. Eradication of Tau accomplished without reducing levels of non-target cytokine. JACKSON CENTER, PA / ACCESSWIRE / February... From Halberd Corporation Via AccessWire Halberd CEO Letter: 2021 Year-End & 2022 Outlook January 25, 2022 JACKSON CENTER, PA / ACCESSWIRE / January 25, 2022 / Greetings From The CEO And Staff At HALBERD CORPORATION! (OTC PINK:HALB) First of all I want to wish all of our shareholders and constituents a Very... From Halberd Corporation Via AccessWire Halberd, Inc. (HALB) Reports Elimination of Target Antigens, Progressing to Treatments for Neurodegenerative Diseases January 13, 2022 JACKSON CENTER, PA / ACCESSWIRE / January 13, 2022 / Halberd, Inc. (OTC PINK:HALB) ("HALB" or the "Company"), an innovative biotech company focused on developing treatments for difficult-to-cure... From Halberd Corporation Via AccessWire Halberd Corporation Now an Official US Government Contractor January 05, 2022 Halberd to bid on Additional Federal Contracts with the Federal Government JACKSON CENTER, PA / ACCESSWIRE / January 5, 2022 / Halberd Corporation (OTC PINK:HALB) is now registered with the Federal... From Halberd Corporation Via AccessWire Halberd Moves Closer to Proving Its Patented Technologies Eliminate Contributors to Neurodegenerative Diseases December 20, 2021 Latest Testing Eliminates Interleukin-2 From Cerebral Spinal Fluid JACKSON CENTER, PA / ACCESSWIRE / December 20, 2021 / Halberd Corporation (OTC Pink:HALB) has been able to successfully eliminate... From Halberd Corporation Via AccessWire Halberd Eradicates Another Inflammatory Cytokine, Interleukin-12, In Its Continuing Effort To Eliminate Neurodegenerative Diseases December 15, 2021 JACKSON CENTER, PA / ACCESSWIRE / December 15, 2021 / Halberd Corporation (OTC PINK:HALB) has demonstrated 100% eradication of Interleukin-12 (IL-12) from synthetic cerebral spinal fluid (CSF) in... From Halberd Corporation Via AccessWire Halberd Successfully Eradicates Interleukin-1 in Its Continued Progress Toward Eliminating Neurodegenerative Diseases December 13, 2021 JACKSON CENTER, PA / ACCESSWIRE / December 13, 2021 / Halberd Corporation (OTC PINK:HALB) has demonstrated 100% eradication of Interleukin-1 (IL-1) from synthetic cerebral spinal fluid (CSF) in... From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Halberd Follow-up Verification Tests Prove 100% Eradication of TNF-alpha, a Major Contributing Factor to Alzheimer's Disease and PTSD/CTE December 06, 2021 JACKSON CENTER, PA / ACCESSWIRE / December 6, 2021 / Halberd Corporation (OTC PINK:HALB) completed verification tests on elimination of Tumor Necrosis Factor-alpha (TNF-alpha) from synthetic cerebral... From Halberd Corporation Via AccessWire Topics Intellectual Property Exposures Intellectual Property Halberd Successfully Eradicates TNF-a, a Major Contributing Factor to Alzheimer’s Disease November 22, 2021 JACKSON CENTER, PA / ACCESSWIRE / November 22, 2021 / Halberd Corporation (OTC PINK:HALB) successfully eradicated 85% of Tumor Necrosis Factor-alpha (TNF-α) from synthetic cerebral spinal fluid (CSF)... From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Halberd Files Additional Extracorporeal Patent Application: Treatment of Covid-19 By Exposure to Tuned Radio Frequency Waves November 08, 2021 JACKSON CENTER, PA / ACCESSWIRE / November 8, 2021 / Halberd Corporation (OTC PINK:HALB) filed a non-provisional patent application for the extracorporeal treatment of Covid-19 through exposure to... From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Halberd Successfully Eradicates IL-6, a Critical Factor in PTSD, CTE & Alzheimer’s Disease November 01, 2021 Elevated levels of IL-6 are believed to be causal factors in PTSD, Chronic Traumatic Encephalopathy, & Alzheimer's Disease. JACKSON CENTER, PA / ACCESSWIRE / November 1, 2021 / Halberd Corporation (OTC... From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Halberd Files Provisional Patent on Breakthrough Obesity Treatment October 25, 2021 JACKSON CENTER, PA / ACCESSWIRE / October 25, 2021 / Halberd Corporation (OTC PINK:HALB) announces the filing of a provisional patent application with the US Patent and Trademark Office covering their... From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Halberd's PTSD/Alzheimer's R&D Reveals Link to Potential Obesity Cure October 20, 2021 JACKSON CENTER, PA / ACCESSWIRE / October 20, 2021 / Halberd Corporation's (OTC PINK:HALB) ongoing research into discovering treatments/cures for PTSD, Alzheimer's Disease, and other neurodegenerative... From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Halberd and GTX Corp. Sign Scientific Collaboration and Reseller Agreement October 12, 2021 GTX and Halberd will begin collaborating on developing and testing treatments for Alzheimer's Disease/PTSD and other neurological diseases and GTX will begin marketing Halberd's VitaShieldMaxTM Immune... From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Halberd Corporation CEO Letter October 07, 2021 JACKSON CENTER, PA / ACCESSWIRE / October 7, 2021 / Greetings From The CEO And Staff At HALBERD CORPORATION! (OTC PINK:HALB) This past quarter, Halberd has made some very significant and unparalleled... From Halberd Corporation Via AccessWire Topics Death Intellectual Property Regulatory Compliance Exposures COVID-19 Death Intellectual Property Halberd's VITASHIELDMAX(TM) Immunity Support Product Available on Amazon October 05, 2021 JACKSON CENTER, PA / ACCESSWIRE / October 5, 2021 / Halberd Corporation (OTC PINK:HALB) announced that its nutraceutical immune support product, VitaShieldMaxTM, is now available through Amazon, in... From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Halberd and heliosDX of RushNet Enter Scientific Collaboration Agreement September 22, 2021 Agreement To Advance Healthcare Diagnostic Technologies JACKSON CENTER, PA / ACCESSWIRE / September 22, 2021 / Halberd Corp. (OTC PINK:HALB) and heliosDx, a wholly owned company of RushNet, Inc. (OTC... From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Halberd's Treatment Eradicates Primary Building Block of Alzheimer’s Disease September 13, 2021 JACKSON CENTER, PA / ACCESSWIRE / September 13, 2021 / Halberd Corporation (OTC PINK:HALB) has successfully eradicated the primary building block of neurofibrillary tangles of Alzheimer's Disease from... From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Halberd Corporation Appoints Anthony Mirabelli Vice-President, Mergers & Acquisitions September 08, 2021 JACKSON CENTER, PA / ACCESSWIRE / September 8, 2021 / Halberd Corporation (OTC PINK:HALB) announced the appointment of Anthony Mirabelli to the position of Vice-President, Mergers & Acquisitions.... From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Halberd Corporation Alzheimer's Disease Treatment Tests Yield Outstanding Results August 30, 2021 JACKSON CENTER, PA / ACCESSWIRE / August 30, 2021 / Halberd Corp. (OTC PINK:HALB) provided an update on its Alzheimer's Disease eradication experimentation being conducted at Youngstown State... From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Halberd Receives Patent for Treatment of Cockayne Syndrome - May Provide Pathway to Slow Aging August 25, 2021 JACKSON CENTER, PA / ACCESSWIRE / August 25, 2021 / Halberd Corporation (OTC PINK:HALB) received notification from the Ference Law Firm in Pittsburgh of a Notice of Allowance, by the US Patent Office,... From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Halberd Files Provisional Patent Application - Furthering Efforts on Alzheimer's Disease August 23, 2021 JACKSON CENTER, PA / ACCESSWIRE / August 23, 2021 / Halberd Corp. (OTC PINK:HALB) announced filing a U. S. joint provisional patent application, "Treating Alzheimer's Disease Utilizing Extracorporeal... From Halberd Corporation Via AccessWire Topics Intellectual Property Exposures COVID-19 Intellectual Property Halberd Corp. VITA-SHIELD-MAX(TM) Available - Buy Now! August 18, 2021 JACKSON CENTER, PA / ACCESSWIRE / August 18, 2021 / Halberd Corporation's (OTC PINK:HALB) Nutraceutical product, Vita-Shield-MaxTM is now available on www.vitashieldmax.com. Vita-Shield-MaxTM is a... From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Halberd’s Disease Elimination Technology R&D at Youngstown State University (YSU) Draws Attention of CBS Affiliate WKBN August 16, 2021 JACKSON CENTER, PA / ACCESSWIRE / August 16, 2021 / Halberd Corporation's (OTC PINK:HALB) research at Youngstown State University (YSU) caught the attention of Youngstown, OH TV news station, WKBN, a... From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Halberd Corporation Adds Blood-Borne Disease Treatment Capability With Addition Of Noted Nephrologist August 11, 2021 JACKSON CENTER, PA / ACCESSWIRE / August 11, 2021 / Halberd Corporation (OTC PINK:HALB) today confirmed the addition of Dr. Ned Kronfol as a member of its Scientific Advisory Board. Dr. Kronfol is... From Halberd Corporation Via AccessWire Topics Death Intellectual Property Regulatory Compliance Exposures COVID-19 Death Intellectual Property Halberd Corporation's VITA-SHIELD-MAX(TM) Immunity Support Product Shipped August 09, 2021 JACKSON CENTER, PA / ACCESSWIRE / August 9, 2021 / Halberd Corporation (OTC PINK:HALB) reports Vita-Shield-MaxTM, has been shipped! With Covid-19 cases back on the rise fueled by the Delta Variant,... From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Halberd Corporation Successfully Establishes Disease Eradication Proof-of-Concept - "Never Before Accomplished" July 28, 2021 A Major Step Towards the Elimination of Multiple Infectious Diseases and Possible Treatment for Alzheimer's Disease/PTSD/CTE JACKSON CENTER, PA / ACCESSWIRE / July 28, 2021 / Halberd Corporation (OTC... From Halberd Corporation Via AccessWire Topics Intellectual Property Exposures COVID-19 Intellectual Property Halberd Corp. Advances the Elimination of Antigens Present in Alzheimer’s Disease & PTSD/Chronic Traumatic Encephalopathy July 22, 2021 JACKSON CENTER, PA / ACCESSWIRE / July 22, 2021 / Halberd Corporation (OTC PINK:HALB) confirms the shipment of samples of metallic nanoparticles conjugated to Alzheimer's Disease (AD) antibodies, Tau... From Halberd Corporation Via AccessWire Topics Intellectual Property Exposures COVID-19 Intellectual Property Halberd Corporation CEO Letter July 06, 2021 Q2-21 Accomplishments and Q3 Plans JACKSON CENTER, PA / ACCESSWIRE / July 6, 2021 / Greetings From The CEO And Staff At HALBERD CORPORATION! (OTC PINK: HALB) As we began the second quarter, the... From Halberd Corporation Via AccessWire Topics Intellectual Property Exposures COVID-19 Intellectual Property Halberd Corp. Discovers a Proprietary Disease-Causing Antigen Removal Process June 30, 2021 Method Does Not Require Antibody Conjugated Metallic Nanoparticles JACKSON CENTER, PA / ACCESSWIRE / June 30, 2021 / Halberd Corporation (OTC PINK:HALB) announces a possible breakthrough method for the... From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.